Monitor for definitive agreement within the 30-day exclusivity period. Shareholder vote and regulatory approvals are required. The CVR structure adds complexity but may provide additional value from legacy asset monetization.
Price Chart
Executive Summary
Nano Dimension (NNDM) announces a non-binding term sheet to acquire Infinite Epigenetics for $890M, pivoting from 3D printing to healthcare AI. The combined company would have over $400M cash and trade as IEAI, with NNDM shareholders retaining a minority stake at a 20% premium to net cash. The deal is transformative but non-binding and subject to due diligence, negotiations, and approvals.
Key Financial Metrics
Key Facts
- Transaction valued at $890 million for Infinite Epigenetics
- Combined company expected to have over $400 million cash at closing
- Existing NNDM shareholders retain meaningful minority ownership at a 20% premium to estimated net cash
- NNDM shareholders to receive a CVR tied to proceeds from legacy asset sales
- Combined company to trade as IEAI under Infinite Epigenetics name
- Non-binding term sheet with 30-day mutual exclusivity period
- Infinite Epigenetics targets $90B+ U.S. clinical diagnostics market with 120,000+ epigenetic samples
Financial Impact
Transaction value of $890M; combined cash >$400M; NNDM market cap $312M
Risk Factors
- Non-binding term sheet may not lead to definitive agreement
- Due diligence and negotiations could fail or alter terms
- Shareholder and regulatory approvals uncertain
- Integration risk and execution of pivot to healthcare AI
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3311691 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 25, 2026 5w ago | 3 | $1.59 $1.58 | ▼ −0.63% | ▼ −0.85% | $1.62 (+1.89%) |
Aug 18, 2026 6w ago | 8-K | $1.55 $1.54 | ▼ −0.65% | ▲ +0.34% | $1.62 (+4.52%) |
Jul 21, 2026 10w ago | 8-K | $1.48 $1.53 | ▲ +3.38% | ▲ +0.48% | $1.62 (+9.46%) |
Jul 14, 2026 11w ago | 144 | $1.50 $1.66 | ▲ +10.67% | ▲ +8.18% | $1.62 (+8.00%) |
Jul 10, 2026 12w ago | DEFA14A | $1.50 $1.63 | ▼ −8.67% | ▼ −6.24% | $1.62 (−8.00%) |
Jun 29, 2026 13w ago | DEFA14A | $1.45 $1.48 | ▲ +2.07% | ▲ +3.10% | $1.62 (+11.72%) |
Jun 16, 2026 15w ago | Press Release | $1.34 $1.48 | ▲ +10.45% | ▲ +9.13% | $1.62 (+20.90%) |
Jun 15, 2026 15w ago | 425 | $1.25 $1.48 | ▲ +18.40% | ▲ +19.15% | $1.62 (+29.60%) |
Jun 15, 2026 15w ago | 8-K | $1.25 $1.48 | ▲ +18.40% | ▲ +19.15% | $1.62 (+29.60%) |
Jun 15, 2026 15w ago | Press Release | $1.25 $1.48 | ▲ +18.40% | ▲ +19.15% | $1.62 (+29.60%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access